2 October 2020
An interim clinical commissioning policy has been in place across the UK since 3 July 2020, defining routine access to remdesivir in the treatment of COVID-19 in adults and children aged 12 years or older. However, due to increased demand against available supply, clinicians are now asked to apply t...
9 September 2020
Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the World Health Organization (WHO) has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease.
3 August 2020
Russell has heard from many members with concerns for at-risk and vulnerable children in this period, and we're now seeking your insights. He also welcomes the UK government's recent announcement about obesity and junk food advertising, but we need to understand how people's lives are and see the de...
13 July 2020
The British Paediatric Surveillance Unit and RCPCH once again invite applications for this bursary from early career paediatricians wishing to undertake an epidemiological study of a rare disease or condition. Winners are awarded a free slot on the BPSU 'Orange eCard' reporting scheme and a stipend ...
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
19 May 2020
The Royal College of Paediatrics and Child Health (RCPCH) and Newlife the Charity for Disabled Children are pleased to announce their first joint clinical research fellowship award in childhood disability has been awarded to Dr Asma Soltani at the University of Cambridge. Dr Soltani will research Re...
18 March 2020
The overall rates of smoking among UK adults and young people have declined in recent decades. Legislation around the consumption, sale and advertisement of cigarettes has become tighter, and wide-reaching public health campaigns have taken effect.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
Surveillance of outcome of resuscitated term babies with no heart rate detected at 10 minutes of age starts next month
5 March 2020
This study, run through the British Paediatric Surveillance Unit (BPSU), will identify the incidence of term babies who receive resuscitation following birth and have no heart rate detected at 10 minutes of age, describing the demographic characteristics, clinical features and initial management of ...
4 March 2020
The RCPCH has today published State of Child Health 2020, the largest ever compilation of data on the health of babies, children and young people across all four UK nations. The report shows that for many measures of children’s health and wellbeing, progress has stalled, or is in reverse – something...